Alnylam Pharmaceuticals, Inc. (ALNY) & Conferences, Synta Pharmaceuticals Corp. (SNTA)’s Investors, Inovio Pharmaceuticals Inc (INO)’s Vaccinations

Editor’s Note: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Inovio Pharmaceuticals Inc (NYSEMKT:INO)

Alnylam Pharmaceuticals, Inc. : Alnylam to Webcast Presentation at Upcoming Investor Conferences (4-Traders)
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that management will present a company overview at the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2013 at 11:10 a.m. ET at the Grand Hyatt in New York City. In addition, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) management will present a company overview at the Stifel 2013 Healthcare Conference on Thursday, September 12, 2013 at 10:55 a.m. ET at the Four Seasons Hotel in Boston.

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Why Synta Pharmaceuticals Corp. (SNTA) May Be Worth Selling (Insider Monkey)
If you’re a Synta Pharmaceuticals Corp. (NASDAQ:SNTA) investor, this data will make you want to rethink your position. Just sayin’. If you were to ask many of your peers, hedge funds are assumed to be overrated, outdated financial vehicles of a forgotten age. Although there are over 8,000 hedge funds trading today, this site focuses on the crème de la crème of this club, close to 525 funds. Analysts calculate that this group has its hands on the lion’s share of all hedge funds’ total capital, and by watching their highest performing equity investments, we’ve brought to light a number of investment strategies that have historically outperformed the broader indices.

Shares in Inovio Pharmaceuticals Inc. Finished Flat on Wednesday (INO) (SBWire)
Inovio Pharmaceuticals Inc (NYSEMKT:INO) is changing the landscape of vaccinations to prevent and cure modern malignancies and complicated contagious illnesses. Its SynCon vaccinations, along with its exclusive electroporation distribution, are producing best-in-class defense reactions, with healing T-cell reactions going above other technology in terms of scale, depth, and reaction rate. Human data to date have shown a positive safety information. Inovio Pharmaceuticals Inc (NYSEMKT:INO)’s lead vaccine, a healing against HPV-caused pre-cancers and malignancies, is in stage II.

Synta Pharmaceuticals Corp. : Synta to Present at the Stifel 2013 Healthcare Conference (4-traders)
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) announced today that the Company will present at the Stifel 2013 Healthcare Conference on Wednesday, September 11, at 3:15 p.m. (EDT) in Boston. Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures.

Inovio Pharmaceuticals to Present at Upcoming Investor Conferences (The Wall St Journal)
Inovio Pharmaceuticals Inc (NYSEMKT:INO), announced today that Dr. J. Joseph Kim, President and CEO, will be presenting a corporate overview of the company at the Rodman & Renshaw Global Investment Conference and the Stifel Nicolaus Weisel Healthcare Conference.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!